Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 0 | 0 | 0 | 0 | -22 |
| Operating Expenses | 107 | 309 | 249 | 206 | 95 |
| Operating Income | -107 | -309 | -249 | -206 | -117 |
| Other Income | 107 | 309 | 249 | 206 | 117 |
| Net Income Continuous | -106 | -308 | -260 | -204 | -135 |
| Net Income | $-106 | $-308 | $-260 | $-204 | $-135 |
| EPS Basic Total Ops | 0.00 | -0.04 | -0.04 | -0.04 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | -0.04 | -0.04 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.04 | -0.04 | -0.04 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | -0.04 | -0.04 | 0.00 |
| EBITDA(a) | $-95 | $-299 | $-240 | $-197 | $-107 |